Logo image of AGN

Allergan Plc (AGN) Stock Fundamental Analysis

USA - NYSE:AGN -

193.02
+0.03 (+0.02%)
Last: 5/8/2020, 8:04:06 PM
193.7
+0.68 (+0.35%)
After Hours: 5/8/2020, 8:04:06 PM
No Fundamental Analysis report for AGN not available.

Allergan Plc

NYSE:AGN (5/8/2020, 8:04:06 PM)

After market: 193.7 +0.68 (+0.35%)

193.02

+0.03 (+0.02%)

Chartmill FA Rating
GICS SectorN/A
GICS IndustryGroupN/A
GICS IndustryN/A
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners0%
Inst Owner Change0%
Ins Owners0.18%
Ins Owner Change0%
Market Cap63.50B
Revenue(TTM)16.10B
Net Income(TTM)-2485000200
Analysts62.6
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 1.53%
Yearly Dividend2.96
Dividend Growth(5Y)1.87%
DP-39.11%
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 10.94
Fwd PE 11.56
P/S 3.95
P/FCF N/A
P/OCF N/A
P/B 1.09
P/tB N/A
EV/EBITDA 28.93
EPS(TTM)17.64
EY9.14%
EPS(NY)16.7
Fwd EY8.65%
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS48.92
BVpS176.36
TBVpSN/A
PEG (NY)N/A
PEG (5Y)2.3
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -2.81%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM -21.34%
PM (TTM) -15.44%
GM N/A
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3Y0%
ROICexgc growth 5Y0%
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score5
Asset Turnover0.18
Health
Industry RankSector Rank
Debt/Equity 0.31
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.01
Quick Ratio 0.84
Altman-Z 1.27
F-Score5
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)5.69%
EPS 3YN/A
EPS 5Y4.76%
EPS Q2Q%21.68%
EPS Next Y-5.33%
EPS Next 2Y1.38%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)2.44%
Revenue growth 3YN/A
Revenue growth 5Y4.87%
Sales Q2Q%0.2%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1YN/A
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1YN/A
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1YN/A
OCF growth 3YN/A
OCF growth 5YN/A

Allergan Plc / AGN FAQ

Can you provide the ChartMill fundamental rating for Allergan Plc?

ChartMill assigns a fundamental rating of 4 / 10 to AGN.


What is the valuation status of Allergan Plc (AGN) stock?

ChartMill assigns a valuation rating of 5 / 10 to Allergan Plc (AGN). This can be considered as Fairly Valued.


Can you provide the profitability details for Allergan Plc?

Allergan Plc (AGN) has a profitability rating of 5 / 10.


What are the PE and PB ratios of Allergan Plc (AGN) stock?

The Price/Earnings (PE) ratio for Allergan Plc (AGN) is 10.94 and the Price/Book (PB) ratio is 1.09.


Can you provide the dividend sustainability for AGN stock?

The dividend rating of Allergan Plc (AGN) is 2 / 10 and the dividend payout ratio is -39.11%.